Saudi Arabia vs Saint Vincent and the Grenadines: Measles-containing-vaccine second-dose (MCV2) immunization coverage
Saudi Arabia
99.0%
in 2025
Saint Vincent and the Grenadines
99.0%
in 2025
Saudi Arabia rank
1st
Saint Vincent and the Grenadines rank
1st
Measles-containing-vaccine second-dose (MCV2) immunization coverage over time
- Saudi Arabia
- Saint Vincent and the Grenadines
How they compare
Saudi Arabia currently reports 99.0% against 99.0% in Saint Vincent and the Grenadines, a difference of 0.0%.
The two have swapped places 6 times across 26 shared years of data; in 2000 it was Saint Vincent and the Grenadines ahead.
Saudi Arabia ranks 1st and Saint Vincent and the Grenadines ranks 1st of 194 countries.
Saudi Arabia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Saudi Arabia | Saint Vincent and the Grenadines | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 87.4% | 80.9% | 6.5% | Saudi Arabia |
| 2010s | 97.1% | 96.1% | 1.0% | Saudi Arabia |
| 2020s | 97.0% | 97.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, Saudi Arabia or Saint Vincent and the Grenadines?
- Saudi Arabia, at 99.0% against 99.0% in Saint Vincent and the Grenadines as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between Saudi Arabia and Saint Vincent and the Grenadines?
- 0.0%, with Saudi Arabia ahead.
- How many years of comparable data are there for Saudi Arabia and Saint Vincent and the Grenadines?
- 26 years are reported by both, from 2000 to 2025.
- How do Saudi Arabia and Saint Vincent and the Grenadines rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Saudi Arabia ranks 1st and Saint Vincent and the Grenadines ranks 1st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.